BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 29697155)

  • 1. Foreword: The CGRP Pathway and Migraine Prevention: Reducing the Burden of Disease.
    Holland PR
    Headache; 2018 May; 58 Suppl 1():1-3. PubMed ID: 29697155
    [No Abstract]   [Full Text] [Related]  

  • 2. CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine.
    Maasumi K; Michael RL; Rapoport AM
    Drugs; 2018 Jun; 78(9):913-928. PubMed ID: 29869205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of CGRP in relation to migraine.
    Edvinsson L; Goadsby PJ
    Cephalalgia; 2019 Mar; 39(3):331-332. PubMed ID: 30827155
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.
    Hargreaves R; Olesen J
    Headache; 2019 Jun; 59(6):951-970. PubMed ID: 31020659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting calcitonin gene-related peptide: a new era in migraine therapy.
    Charles A; Pozo-Rosich P
    Lancet; 2019 Nov; 394(10210):1765-1774. PubMed ID: 31668411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
    Tepper SJ
    Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications.
    Dodick DW
    Cephalalgia; 2019 Mar; 39(3):445-458. PubMed ID: 30661365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CGRP Pathway in Migraine as a Viable Target for Therapies.
    Edvinsson L
    Headache; 2018 May; 58 Suppl 1():33-47. PubMed ID: 29697153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eptinezumab: First Approval.
    Dhillon S
    Drugs; 2020 May; 80(7):733-739. PubMed ID: 32266704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitonin Gene-Related Peptide Antagonists in the Treatment of Episodic Migraine.
    Yuan H; White CS; Silberstein SD
    Clin Pharmacol Ther; 2019 May; 105(5):1121-1129. PubMed ID: 30648737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CGRP as the target of new migraine therapies - successful translation from bench to clinic.
    Edvinsson L; Haanes KA; Warfvinge K; Krause DN
    Nat Rev Neurol; 2018 Jun; 14(6):338-350. PubMed ID: 29691490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking the CGRP Pathway for Acute and Preventive Treatment of Migraine: The Evolution of Success.
    Dubowchik GM; Conway CM; Xin AW
    J Med Chem; 2020 Jul; 63(13):6600-6623. PubMed ID: 32058712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitonin Gene-Related Protein (CGRP)-Targeted Treatments for Migraine Prevention.
    Tepper DE
    Headache; 2019 Mar; 59(3):477-480. PubMed ID: 30825209
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcitonin Gene-Related Peptide (CGRP) Antagonists and Their Use in Migraines.
    Henson B; Hollingsworth H; Nevois E; Herndon C
    J Pain Palliat Care Pharmacother; 2020 Mar; 34(1):22-31. PubMed ID: 31763951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of Monoclonal Antibody Therapies and Other Preventative Treatments in Migraine.
    Reuter U
    Headache; 2018 May; 58 Suppl 1():48-59. PubMed ID: 29697156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new era for migraine: The role of calcitonin gene-related peptide in the trigeminovascular system.
    Chen ST; Wu JW
    Prog Brain Res; 2020; 255():123-142. PubMed ID: 33008504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigens and Antibodies in Disease With Specifics About CGRP Immunology.
    Taylor FR
    Headache; 2018 Nov; 58 Suppl 3():230-237. PubMed ID: 30187471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical spreading depression as a site of origin for migraine: Role of CGRP.
    Close LN; Eftekhari S; Wang M; Charles AC; Russo AF
    Cephalalgia; 2019 Mar; 39(3):428-434. PubMed ID: 29695168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.
    Bigal ME; Walter S; Rapoport AM
    Headache; 2013 Sep; 53(8):1230-44. PubMed ID: 23848260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the brainstem in migraine: Potential brainstem effects of CGRP and CGRP receptor activation in animal models.
    Holland PR; Saengjaroentham C; Vila-Pueyo M
    Cephalalgia; 2019 Mar; 39(3):390-402. PubMed ID: 29411638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.